Literature DB >> 8977724

Bacillary angiomatosis in an HIV seronegative patient on systemic steroid therapy.

R A Schwartz1, M A Gallardo, R Kapila, P Gascón, J Herscu, I Siegel, W C Lambert.   

Abstract

Bacillary angiomatosis is an unusual systemic vascular proliferation seen predominantly in patients with the acquired immunodeficiency syndrome. These vascular lesions are due to infection with a Bartonella species, most commonly B. henselae, but sometimes B. quintana. It is treatable and often curable, but without therapy may be life-threatening. Clinically, the disorder often resembles several different vascular disorders, particularly pyogenic granuloma and Kaposi's sarcoma. We now report a clinically typical patient with bacillary angiomatosis who was HIV seronegative, but who had idiopathic thrombocytopenic purpura, was status-post splenectomy and to whom long-term systemic prednisone had been administered.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8977724     DOI: 10.1046/j.1365-2133.1996.d01-1107.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  2 in total

1.  Clinical challenge: cutaneous Kaposi's sarcoma of the lower extremity.

Authors:  Erika L Johnson; Yvonne N Pierpont; Guillermo Donate; Mattew H Hiro; Rudolph J Mannari; Theodore J Strickland; Martin C Robson; Wyatt G Payne
Journal:  Int Wound J       Date:  2011-02-11       Impact factor: 3.315

2.  An unusual case of bacillary angiomatosis in the oral cavity of an AIDS patient who had no concomitant tegumentary lesions - case report and review.

Authors:  Walter de Araujo Eyer-Silva; Pedro Eugênio Mendes Arena Soares; Marcelo Costa Velho Mendes de Azevedo; Guilherme Almeida Rosa da Silva; Dario José Hart Pontes Signorini; Rogerio Neves-Motta; Jorge Francisco da Cunha Pinto; Lívia Machado Moura; Rodrigo Panno Basílio-de-Oliveira; Luciana Ferreira de Araujo; Alexsandra Rodrigues de Mendonça Favacho; Elba Regina Sampaio Lemos
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2017-08-24       Impact factor: 1.846

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.